These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 25683595)
1. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood. Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595 [TBL] [Abstract][Full Text] [Related]
2. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
3. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
4. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients. Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy. Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study. Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy. Pasha I; Kamate M; Didagi SK Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy. Farkas MK; Makedonska I; Beller C; Bourikas D; de la Loge C; Dimova S; Floricel F; McClung C; Moseley B; Therriault S; Pina-Garza JE Epilepsy Behav; 2024 Oct; 159():109989. PubMed ID: 39216464 [TBL] [Abstract][Full Text] [Related]
12. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy. Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806 [TBL] [Abstract][Full Text] [Related]
13. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484 [TBL] [Abstract][Full Text] [Related]
14. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice. Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580 [TBL] [Abstract][Full Text] [Related]
15. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial. Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S; Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101 [TBL] [Abstract][Full Text] [Related]
16. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
17. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ; Kelly K; Stephen LJ Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [TBL] [Abstract][Full Text] [Related]
18. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy. Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372 [TBL] [Abstract][Full Text] [Related]
20. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort. McGinnis E; Kessler SK Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]